← All First Tracks Biotherapeutics, INC filings

First Tracks Biotherapeutics, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
TRAX
First Tracks Biotherapeutics, INC
SCHEDULE: Sirenia Capital Management Reports 7.2% Stake in First Tracks Biotherapeutics
Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 7.2% of First Tracks Biotherapeutics, Inc. common stock.
NASDAQ
TRAX
First Tracks Biotherapeutics, INC
SCHEDULE: Affinity Asset Advisors Discloses 5.8% Stake in First Tracks Biotherapeutics
Affinity Asset Advisors, LLC and Michael Cho have jointly reported beneficial ownership of 2,032,012 shares, representing 5.8% of First Tracks Biotherapeutics, Inc. common stock as of June 30, 2026.
NASDAQ
TRAX
First Tracks Biotherapeutics, INC
SCHEDULE: FMR LLC Reports Stake in First Tracks Biotherapeutics
FMR LLC and Abigail P. Johnson have reported a beneficial ownership stake of 5.9% in First Tracks Biotherapeutics Inc. as of June 30, 2026.